| |
| |
|
| Insider
Information: |
Spellman David A |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
446,483 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$611,682 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
446,483 |
|
|
| Total
Value |
$611,682 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -122.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mersana Therapeutics, Inc. |
MRSN |
|
|
0 |
|
0 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2023-05-16 |
446,483 |
2021-02-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO and Treasurer |
• – – |
2023-05-16 |
4 |
S |
$1.07 |
$67,890 |
D/D |
(63,567) |
446,483 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO and Treasurer |
• – – |
2023-03-01 |
4 |
S |
$0.88 |
$6,327 |
D/D |
(7,210) |
510,050 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO and Treasurer |
• – – |
2023-02-27 |
4 |
S |
$0.81 |
$6,131 |
D/D |
(7,539) |
517,260 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO and Treasurer |
• – – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
196,200 |
524,799 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO and Treasurer |
• – – |
2022-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
328,599 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO and Treasurer |
• – – |
2022-03-01 |
4 |
S |
$2.17 |
$1,743 |
D/D |
(803) |
128,599 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO and Treasurer |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
129,402 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO and Treasurer |
• – – |
2022-02-28 |
4 |
S |
$2.15 |
$15,946 |
D/D |
(7,400) |
69,402 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO and Treasurer |
• – – |
2021-04-01 |
4 |
S |
$3.40 |
$2,686 |
D/D |
(790) |
76,802 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO and Treasurer |
• – – |
2021-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,592 |
77,592 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO and Treasurer |
• – – |
2021-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
70,000 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
